HYDROCORTISONE SODIUM SUCCINATE. Key specifications include physical_form: POWDER, administration: INTRAMUSCULAR OR INTRAVENOUS, features_provided: THINNER, primary_container_type: VIAL, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 8.000 MILLILITERS AFTER RECONSTITUTION. This product is currently in active production with full OEM support.
This part is cataloged in the Federal Logistics Information System (FLIS) under NSN 6505-00-238-5222, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| physical_form | POWDER |
| administration | INTRAMUSCULAR OR INTRAVENOUS |
| special_features | EACH WHEN MIXED CONTAINS 8 MG MONOBASIC SODIUM PHOSPHATE ANHYDROUS; 88 MG DIBASIC SODIUM PHOSPHATE DRIED AND 66.9 OR 72 MG BENZYL ALCOHOL AS PRESERVATIVE; 2 COMPARTMENT VIAL |
| features_provided | THINNER |
| primary_container_type | VIAL |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| primary_container_content_quantity | 8.000 MILLILITERS AFTER RECONSTITUTION |
| active_medicament_medicinal_strength | 1000.000 MILLIGRAMS HYDROCORTISONE EQUIVALENT |
| NSN | 6505-00-238-5222 |
| PRIMARY CONTAINER TYPE | VIAL |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| ADMINISTRATION | INTRAMUSCULAR OR INTRAVENOUS |
| FEATURES PROVIDED | THINNER |
| SPECIAL FEATURES | EACH WHEN MIXED CONTAINS 8 MG MONOBASIC SODIUM PHOSPHATE ANHYDROUS; 88 MG DIBASIC SODIUM PHOSPHATE DRIED AND 66.9 OR 72 MG BENZYL ALCOHOL AS PRESERVATIVE; 2 COMPARTMENT VIAL |
| PHYSICAL FORM | POWDER |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 1000.000 MILLIGRAMS HYDROCORTISONE EQUIVALENT |
| PRIMARY CONTAINER CONTENT QUANTITY | 8.000 MILLILITERS AFTER RECONSTITUTION |